TRCT
SGTX

Tower Research Capital (TRC)’s Sigilon Therapeutics, Inc. Common Stock SGTX Stock Holding History

Tower Research Capital (TRC)’s Portfolio SGTX Stock Details SGTX Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
2023
Q2 		$46.6K Buy
2023
Q1 		$12K Buy
2022
Q4 		$4K Sell
2022
Q3 		$6K Buy
2022
Q2 		$3K Sell
2022
Q1 		$14K Buy
2021
Q4 		$10K Sell
2021
Q3 		$26K Buy
2021
Q2 		$13K Buy
2021
Q1 		$19K Buy